Diagnosis and treatment of complicated forms of atopic dermatitis in children



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article deals with a clinical and diagnostic criteria and character of skin lesions in children with atopic dermatitis and second infection. Various factors are analysed that influence the course of the disease at different infections, the basic principles of therapy of atopic dermatitis with infections are discussed.

Full Text

Restricted Access

About the authors

G I Smirnova

I.M. Sechenov First Moscow state Medical University

Email: gismirnova@yandex.ru

References

  1. Spergel J.M. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin. North Am. 2010, v. 30, р. 269-280.
  2. Смирнова Г.И. Современная концепция лечения атопического дерматита. М., «Прима-Центр». 2006, 132 с.
  3. Eichenfield L.F., Ellis C.N., Mancini A.J. et al. Atopic dermatitis: epidemiology and pathogenesis update. Semin. Cutan. Med. Surg. 2012, v. 31, р. 3-5.
  4. Williams H.C. Epidemiology of human atopic dermatitis - seven areas of notable progress and seven areas of notable ignorance. Vet. Dermatol. 2013, v. 24, р. 3-9.
  5. Leung D.Y New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol. Int. 2013, v. 62, р. 151-161.
  6. Смирнова Г.И. Новое в патогенезе и лечении атопического дерматита у детей. Рос. педиатр. журн. 2013, № 6, с. 53-57.
  7. Kubo A., Nagao K., Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 2012, v. 122, р. 440-447.
  8. McAleer M.A., Irvine A.D. The multifunctional role of filaggrin in allergic skin disease. J. Allergy Clin. Immunol. 2013, v. 131, р. 280-291.
  9. Kendall A.C., Nicolaou A. Bioactive lipid mediators in skin inflammation and immunity. Prog. Lipid Res. 2013, v. 52, р. 141-164.
  10. Grice E.A., Segre J.A. The skin microbiome. Nat. Rev. Microbiol. 2011, v. 9, р. 244-253.
  11. Na S.Y., Roh J.Y., Kim J.M. еt al. Analysis of Colonization and Genotyping of the Exotoxins of Staphylococcus aureus in Patients with Atopic Dermatitis. Ann. Dermatol. 2012, v. 24, р. 413-419.
  12. Petry V., Bessa G.R., Poziomczyck C.S. et al. Bacterial skin colonization and infections in patients with atopic dermatitis. An. Bras. Dermatol. 2012, v. 87, р. 729-734.
  13. Смирнова Г.И. Современные технологии диагностики и лечения тяжелых форм аллергодерматозов у детей. М., «Альба Плюс». 2006, 156 с.
  14. Macleod A.S., Hemmers S., Garijo O. et al. Dendritic epidermal T-cells regulate skin antimicrobial barrier function. J. Clin. Invest. 2013, v. 123, р. 4364-4374.
  15. Park H.Y., Kim C.R., Huh I.S. et al. Staphylococcus aureus Colonization in Acute and Chronic Skin Lesions of Patients with Atopic Dermatitis. Ann. Dermatol. 2013, v. 25, р. 410-416.
  16. Смирнова Г.И. Диагностика и cовременные методы лечения аллергодерматозов у детей. Рос. педиатр. журн. 2002, № 3, с. 40-44.
  17. Ott H., Weißmantel S., Kennes L.N. et al. Molecular microarray analysis reveals allergen- and exotoxin-specific IgE repertoires in children with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2014, v. 28, р. 100-107.
  18. Zhang E., Tanaka T., Tajima M. et al. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol. Immunol. 2011, v. 55, р. 625-632.
  19. Salgado-Pabón W., Case-Cook L.C., Schlievert P.M. Molecular analysis of staphylococcal superantigens. Methods Mol. Biol. 2014, v. 1085, р. 169-185.
  20. Zeeuwen P.L., Kleerebezem M., Timmerman H.M. et al. Microbiome and skin diseases. Curr. Opin. Allergy Clin. Immunol. 2013, v. 13, р. 514-520.
  21. Spaulding A.R., Salgado-Pabón W., Kohler P.L. et al. Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol. Rev. 2013, v. 26, р. 422-447.
  22. Zuniga R., Nguyen T. Skin conditions: common skin rashes in infants. FP Essent. 2013, № 407, р. 31-41.
  23. Dreyfus D.H. Herpesviruses and the microbiome. J. Allergy Clin. Immunol. 2013, v. 132, р. 1278-1286.
  24. Wollenberg A. Eczema herpeticum. Chem Immunol Allergy. 2012, v. 96, р. 89-95.
  25. Gao P.S., Rafaels N.M., Hand T. et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J. Allergy Clin. Immunol. 2009, v. 124, р. 507-513.
  26. Bin L., Kim B.E., Brauweiler A. et al. Staphylococcus aureus α-toxin modulates skin host response to viral infection. J. Allergy Clin. Immunol. 2012, v. 130, р. 683-691.
  27. Difonzo E.M., Faggi E., Bassi A. et al. Malassezia skin diseases in humans. G Ital. Dermatol. Venereol. 2013, v. 148, р. 609-619.
  28. Gaitanis G., Velegraki A., Mayser P et al. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin. Dermatol. 2013, v. 31, р. 455-463.
  29. Park M., Do E., Jung W.H. Lipolytic enzymes involved in the virulence of human pathogenic fungi. Mycobiology. 2013, v. 41, р. 67-72.
  30. Seng P., Abat C., Rolain J.M. et al. Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 2013, v. 51, р. 2182-2194.
  31. Kooken J., Fox K., Fox A. et al. Identification of staphylococcal species based on variations in protein sequences (mass spectrometry) and DNA sequence (sodA microarray). Mol. Cell Probes. 2014, v. 28, р. 41-50.
  32. Biswas S., Rolain J.M. Use of MALDI-TOF mass spectrometry for identification of bacteria that are difficult to culture. J. Microbiol Methods. 2013, v. 92, р. 14-24.
  33. Haigh J.D., Green I.M., Ball D. et al. Rapid identification of bacteria from bioMérieux BacT/ALERT blood culture bottles by MALDI-TOF MS. Br. J. Biomed Sci. 2013, v. 70, р. 149-155.
  34. Cobo F. Application of maldi-tof mass spectrometry in clinical virology: a review. Open Virol. J. 2013, v. 7, р. 84-90.
  35. Смирнова Г.И. Эффективное лечение атопического дерматита у детей. Рос. педиатр. журн. 2012, № 5, с. 23-30.
  36. Tan A.U., Gonzalez M.E. Management of severe atopic dermatitis in children. J. Drugs Dermatol. 2012, v. 11, р. 1158-1165.
  37. Lim H., Song K., Kim R. et al. Nutrient intake and food restriction in children with atopic dermatitis. Clin. Nutr. Res. 2013, v. 2, р. 52-58.
  38. Foolad N., Brezinski E.A., Chase E.P. et al. Effect of Nutrient Supplementation on Atopic Dermatitis in Children: A Systematic Review of Probiotics, Prebiotics, Formula, and Fatty Acids. Arch. Dermatol. 2012, v. 17, р. 1-6.
  39. Смирнова Г.И. Энтеросорбенты в комплексном лечении атопического дерматита у детей. Рос. педиатр. журн. 2009, № 1, с. 41-44.
  40. Balato A., Paoletti I., De Gregorio V. et al. Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes. Mycoses. 2014, v. 57, р. 176-183.
  41. Fleischer A.B. Jr, Feldman S.R. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Clin. Ther. 1999, v. 21, р. 1725-1731.
  42. Greenberg H.L., Shwayder T.A., Bieszk N. et al. Clotrimazole/ betamethasone dipropionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatr Dermatol. 2002, v. 19, р. 78-81.
  43. Смирнова Г.И. Эмольянты в наружной терапии атопического дерматита у детей. Рос. педиатр. журн. 2011, № 4, с. 37-42.
  44. Boralevi F., Saint Aroman M., Delarue A. et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J. Eur. Acad. Dermatol Venereol. 2013; doi: 10.1111/ jdv.12314.
  45. Schäkel K., Döbel T., Bosselmann I. Future treatment options for atopic dermatitis - Small molecules and beyond. J. Dermatol. Sci. 2014, v. 73, р. 91-100.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2014



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies